ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintIcon Twitter

Nobel laureate asks Fujifilm to keep licensing fees low

Stem cell pioneer wary of patent fees impeding regenerative medicine

Building a stock of induced pluripotent stem cells is a public service project, said professor Shinya Yamanaka of Kyoto University.

TOKYO -- A noted Japanese stem cell researcher has asked Fujifilm Holdings to keep fees in check for using patented technology related to induced pluripotent stem cells, he told The Nikkei on Wednesday.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more